{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T04:28:03Z","timestamp":1785472083972,"version":"3.56.0"},"reference-count":19,"publisher":"Spandidos Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.3892\/mmr.2013.1588","type":"journal-article","created":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T10:22:02Z","timestamp":1373970122000},"page":"861-864","source":"Crossref","is-referenced-by-count":20,"title":["Rosiglitazone inhibits insulin-like growth factor-1-induced polycystic kidney disease cell growth and p70S6 kinase activation"],"prefix":"10.3892","volume":"8","author":[{"given":"CHUNYAN","family":"LIU","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YI","family":"ZHANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LI","family":"YUAN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LILI","family":"FU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CHANGLIN","family":"MEI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2013,7,16]]},"reference":[{"key":"key20180108013317_b1-mmr-08-03-0861","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/S0140-6736(07)60601-1","article-title":"Autosomal dominant polycystic kidney disease","volume":"369","author":"Torres","year":"2007","journal-title":"Lancet"},{"key":"key20180108013317_b2-mmr-08-03-0861","doi-asserted-by":"crossref","first-page":"C270","DOI":"10.1159\/000320745","article-title":"Demographic and clinical characteristics of patients with autosomal dominant polycystic kidney disease: a multicenter experience","volume":"117","author":"Kazancioglu","year":"2011","journal-title":"Nephron Clin Pract"},{"key":"key20180108013317_b3-mmr-08-03-0861","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1210\/edrv.22.6.0452","article-title":"Distinct and overlapping functions of insulin and IGF-I receptors","volume":"22","author":"Nakae","year":"2001","journal-title":"Endocr Rev"},{"key":"key20180108013317_b4-mmr-08-03-0861","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/nrc1387","article-title":"Insulin-like growth factors and neoplasia","volume":"4","author":"Pollak","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"key20180108013317_b5-mmr-08-03-0861","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1681\/ASN.V371378","article-title":"Growth factor gene expression in kidney of murine polycystic kidney disease","volume":"3","author":"Nakamura","year":"1993","journal-title":"J Am Soc Nephrol"},{"key":"key20180108013317_b6-mmr-08-03-0861","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S1470-2045(04)01509-8","article-title":"Antineoplastic effects of peroxisome proliferator-activated receptor gamma agonists","volume":"5","author":"Grommes","year":"2004","journal-title":"Lancet Oncol"},{"key":"key20180108013317_b7-mmr-08-03-0861","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1056\/NEJMra041001","article-title":"Thiazolidinediones","volume":"351","author":"Yki-J\u00e4rvinen","year":"2004","journal-title":"N Engl J Med"},{"key":"key20180108013317_b8-mmr-08-03-0861","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1093\/hmg\/11.15.1731","article-title":"Pioglitazone improves the phenotype and molecular defects of a targeted Pkd1 mutant","volume":"11","author":"Muto","year":"2002","journal-title":"Hum Mol Genet"},{"key":"key20180108013317_b9-mmr-08-03-0861","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1042\/CS20100113","article-title":"Rosiglitazone attenuates development of polycystic kidney disease and prolongs survival in Han: SPRD rats","volume":"119","author":"Dai","year":"2010","journal-title":"Clin Sci (Lond)"},{"key":"key20180108013317_b10-mmr-08-03-0861","doi-asserted-by":"crossref","first-page":"274376","DOI":"10.1155\/2010\/274376","article-title":"Pioglitazone attenuates cystic burden in the PCK rodent model of polycystic kidney disease","volume":"2010","author":"Blazer-Yost","year":"2010","journal-title":"PPAR Res"},{"key":"key20180108013317_b11-mmr-08-03-0861","doi-asserted-by":"crossref","first-page":"F397","DOI":"10.1152\/ajprenal.00310.2002","article-title":"Immortalized epithelial cells from human autosomal dominant polycystic kidney cysts","volume":"285","author":"Loghman-Adham","year":"2003","journal-title":"Am J Physiol Renal Physiol"},{"key":"key20180108013317_b12-mmr-08-03-0861","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2174\/138920310791824093","article-title":"The complexes of mammalian target of rapamycin","volume":"11","author":"Zhou","year":"2010","journal-title":"Curr Protein Pept Sci"},{"key":"key20180108013317_b13-mmr-08-03-0861","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/ki.2009.128","article-title":"Autosomal dominant polycystic kidney disease: the last 3 years","volume":"76","author":"Torres","year":"2009","journal-title":"Kidney Int"},{"key":"key20180108013317_b14-mmr-08-03-0861","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/MNH.0b013e3283262ab0","article-title":"Advances in the pathogenesis and treatment of polycystic kidney disease","volume":"18","author":"Patel","year":"2009","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"key20180108013317_b15-mmr-08-03-0861","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/sj.ki.5002229","article-title":"Hyperproliferation of PKD1 cystic cells is induced by insulin-like growth factor-1 activation of the Ras\/Raf signalling system","volume":"72","author":"Parker","year":"2007","journal-title":"Kidney Int"},{"key":"key20180108013317_b16-mmr-08-03-0861","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00005-008-0037-y","article-title":"Structure and physiological functions of the human peroxisome proliferator-activated receptor gamma","volume":"56","author":"Zieleniak","year":"2008","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"key20180108013317_b17-mmr-08-03-0861","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nrc1254","article-title":"Peroxisome-proliferator-activated receptors and cancers: complex stories","volume":"4","author":"Michalik","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"key20180108013317_b18-mmr-08-03-0861","doi-asserted-by":"crossref","first-page":"5466","DOI":"10.1073\/pnas.0509694103","article-title":"The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease","volume":"103","author":"Shillingford","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180108013317_b19-mmr-08-03-0861","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1158\/1535-7163.MCT-05-0347","article-title":"Rosiglitazone suppresses human lung carcinoma cell growth through PPARgamma-dependent and PPARgamma-independent signal pathways","volume":"5","author":"Han","year":"2006","journal-title":"Mol Cancer Ther"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/mmr.2013.1588\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T05:20:59Z","timestamp":1646112059000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mmr.2013.1588"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,16]]},"references-count":19,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2013,7,16]]},"published-print":{"date-parts":[[2013,9]]}},"alternative-id":["10.3892\/mmr.2013.1588"],"URL":"https:\/\/doi.org\/10.3892\/mmr.2013.1588","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,16]]}}}